Greg A Brown

US Patent:

7737145, Jun 15, 2010

Filed:

Dec 22, 2006

Appl. No.:

11/644244

Inventors:

Damian Arnaiz - El Sobrante CA, US
Greg Brown - Oakland CA, US
Emmanuel Claret - Besancon, FR
Arwed Cleve - Berlin, DE
David Davey - El Sobrante CA, US
William Guilford - Belmont CA, US
Thomas Kirkland - Atascadero CA, US
Monica J. Kochanny - Benicia CA, US
Amy Liang - Vallejo CA, US
David Light - San Mateo CA, US
John Parkinson - Martinez CA, US
David Vogel - Richmond CA, US
Guo Ping Wei - San Ramon CA, US
Bin Ye - Moraga CA, US

Assignee:

Estrellita Pharmaceuticals, LLC - Martinez CA

International Classification:

A01N 43/60
A61K 31/495
C07D 241/36
C07D 271/00
C07D 487/00
C07D 491/00
C07D 495/00
C07D 497/00
C07D 498/00
C07D 513/00

US Classification:

514248, 544338

Abstract:

This invention is directed to compounds of formula (I):.

US Patent:

8569303, Oct 29, 2013

Filed:

Apr 30, 2010

Appl. No.:

12/771659

Inventors:

Damian O Arnaiz - El Sobrante CA, US
Greg Brown - Oakland CA, US
Emmanuel Claret - Besancon, FR
Arwed Cleve - Berlin, GR
David Davey - El Sobrante CA, US
William Guilford - Belmont CA, US
Thomas Kirkland - Atascadero CA, US
Monica J Kochanny - Benicia CA, US
Amy Liang - Vallejo CA, US
David Light - San Mateo CA, US
John Parkinson - Martinez CA, US
David Vogel - Richmond CA, US
Guo Ping Wei - San Ramon CA, US
Bin Ye - Moraga CA, US

Assignee:

Celtaxsys, Inc. - Atlanta GA

International Classification:

A61K 31/495
C07D 241/36

US Classification:

5142521, 544224, 544338, 544349, 514247

Abstract:

This invention is directed to compounds of formula (I):.

US Patent:

20080170622, Jul 17, 2008

Filed:

Jan 11, 2008

Appl. No.:

12/008697

Inventors:

Donald Gordon - Mountain View CA, US
Lena Y. Pavlovskaia - Cupertino CA, US
Airan Landau - San Jose CA, US
Andreas Lennartsson - Manchester MD, US
Charlie Lawrence - Fremont CA, US
Greg Brown - Fremont CA, US
Edward Ludvig - Redwood City CA, US

Assignee:

ICTV, Inc. - San Jose CA

International Classification:

H04N 11/02

US Classification:

37524018, 37524024, 375E07076

Abstract:

A system for creating composite encoded video from two or more encoded video sources in the encoded domain. In response to user input, a markup language-based graphical layout is retrieved. The graphical layout includes frame locations within a composite frame for at least a first encoded source and a second encoded source. The system either retrieves or receives the first and second encoded sources. The sources include block-based transform encoded data. The system also includes a stitcher module for stitching together the first encoded source and the second encoded source according to the frame locations of the graphical layout to form an encoded frame. The system outputs an encoded video stream that is transmitted to a client device associated with the user. In response to further user input, the system updates the state of an object model and replaces all or a portion of one or more frames of the encoded video stream. The system may be used with MPEG encoded video.

US Patent:

20130123243, May 16, 2013

Filed:

Oct 18, 2012

Appl. No.:

13/654669

Inventors:

Greg Brown - Oakland CA, US
Emmanuel Claret - Besancon, FR
Arwed Cleve - Berlin, DE
David Davey - El Sobrante CA, US
William Guilford - Belmont CA, US
Thomas Kirkland - Atascadero CA, US
Monica J. Kochanny - Benicia CA, US
Amy Liang - Vallejo CA, US
David Light - San Mateo CA, US
John Parkinson - Martinez CA, US
David Vogel - Richmond CA, US
Guo Ping Wei - San Ramon CA, US
Bin Ye - Moraga CA, US

International Classification:

C07D 487/08
C07D 263/32
C07D 211/58
C07D 211/26
C07D 207/09
C07D 295/096
C07D 403/12
C07D 405/12
C07D 409/12
C07D 413/12
C07D 401/10
C07C 229/38
C07D 243/08
C07D 451/04

US Classification:

514218, 548236, 514374, 540575, 546223, 514329, 546235, 514331, 548566, 514408, 546124, 514304, 544137, 5142368, 548453, 514412, 514414, 548247, 514378, 548181, 514365, 562451, 544398

Abstract:

This invention is directed to compounds of formula (I):where r, q, R, R, R, R, R, R, R, R, R, R, R, R, and Rare described herein, as single stereoisomers or as mixtures of stereoisomers, or pharmaceutically acceptable salts, solvates, clathrates, polymorphs, ammonium ions, N-oxides or prodrugs thereof; which are leukotriene Ahydrolase inhibitors and therefore useful in treating inflammatory disorders. Pharmaceutical compositions comprising the compounds of the invention and methods of preparing the compounds of the invention are also disclosed.

US Patent:

20200308181, Oct 1, 2020

Filed:

Jan 9, 2020

Appl. No.:

16/738190

Inventors:

- Atlanta GA, US
Greg Brown - Oakland CA, US
Emmanuel Claret - Besancon, FR
Arwed Cleve - Berlin, DE
David Davey - Landing NJ, US
William Guilford - Belmont CA, US
Seock-Kyu Khim - Orinda CA, US
Thomas Kirkland - Atascadero CA, US
Monica J. Kochanny - Benicia CA, US
Amy Liang - Vallejo CA, US
David Light - San Mateo CA, US
John Parkinson - Martinez CA, US
Guo Ping Wei - San Ramon CA, US
Bin Ye - Moraga CA, US

International Classification:

C07D 487/08
C07C 217/58
C07C 229/38
C07C 233/78
C07C 255/57
C07C 271/20
C07D 207/04
C07D 211/58
C07D 243/08
C07D 295/04
C07D 295/16
C07D 451/04
C07D 207/09
C07D 211/26
C07D 263/32
C07D 295/096
C07D 401/10
C07D 403/12
C07D 405/12
C07D 409/12
C07D 413/12
C07C 229/08
C07D 263/14
C07D 401/12
C07D 207/16
C07D 211/34
C07D 277/22
C07D 277/68
C07D 451/02

Abstract:

This invention is directed to compounds of formula (I):where r, q, R, R, R, R, R, R, R, R, R, R, R, R, and Rare described herein, as single stereoisomers or as mixtures of stereoisomers, or pharmaceutically acceptable salts, solvates, clathrates, polymorphs, ammonium ions, N-oxides or prodrugs thereof; which are leukotriene Ahydrolase inhibitors and therefore useful in treating inflammatory disorders. Pharmaceutical compositions comprising the compounds of the invention and methods of preparing the compounds of the invention are also disclosed.

US Patent:

20180230159, Aug 16, 2018

Filed:

Feb 8, 2018

Appl. No.:

15/891585

Inventors:

- Atlanta GA, US
Greg Brown - Oakland CA, US
Emmanuel Claret - Besancon, FR
Arwed Cleve - Berlin, DE
David Davey - Landing NJ, US
William Guilford - Belmont CA, US
Seock-Kyu Khim - Orinda CA, US
Thomas Kirkland - Atascadero CA, US
Monica J. Kochanny - Benicia CA, US
Amy Liang - Vallejo CA, US
David Light - San Mateo CA, US
John Parkinson - Martinez CA, US
Guo Ping Wei - San Ramon CA, US
Bin Ye - Moraga CA, US

International Classification:

C07D 487/08
C07D 263/32
C07C 271/20
C07D 211/58
C07C 229/38
C07C 229/08
C07D 295/096
C07C 255/57
C07D 211/34
C07D 207/04
C07D 401/12
C07D 243/08
C07D 295/16
C07D 295/04
C07D 451/04
C07D 277/68
C07D 401/10
C07C 217/58
C07D 207/09
C07D 405/12
C07D 403/12
C07D 409/12
C07D 211/26
C07D 413/12
C07D 451/02
C07D 277/22
C07C 233/78
C07D 263/14
C07D 207/16

Abstract:

This invention is directed to compounds of formula (I):where r, q, R, R, R, R, R, R, R, R, R, R, R, R, and Rare described herein, as single stereoisomers or as mixtures of stereoisomers, or pharmaceutically acceptable salts, solvates, clathrates, polymorphs, ammonium ions, N-oxides or prodrugs thereof; which are leukotriene Ahydrolase inhibitors and therefore useful in treating inflammatory disorders. Pharmaceutical compositions comprising the compounds of the invention and methods of preparing the compounds of the invention are also disclosed.

US Patent:

20160272649, Sep 22, 2016

Filed:

Mar 14, 2016

Appl. No.:

15/069484

Inventors:

- Atlanta GA, US
Greg Brown - Oakland CA, US
Emmanuel Claret - Besancon, FR
Arwed Cleve - Berlin, DE
David Davey - Landing NJ, US
William Guilford - Belmont CA, US
Seock-Kyu Khim - Orinda CA, US
Thomas Kirkland - Atascadero CA, US
Monica J. Kochanny - Benicia CA, US
Amy Liang - Vallejo CA, US
David Light - San Mateo CA, US
John Parkinson - Martinez CA, US
Guo Ping Wei - San Ramon CA, US
Bin Ye - Moraga CA, US

International Classification:

C07D 487/08
C07D 263/32
C07D 211/58
C07D 277/22
C07D 207/09
C07D 207/16
C07D 451/02
C07D 277/68
C07D 295/16
C07D 211/34

Abstract:

This invention is directed to compounds of formula (I):where r, q, R, R, R, R, R, R, R, R, R, R, R, R, and Rare described herein, as single stereoisomers or as mixtures of stereoisomers, or pharmaceutically acceptable salts, solvates, clathrates, polymorphs, ammonium ions, N-oxides or prodrugs thereof; which are leukotriene Ahydrolase inhibitors and therefore useful in treating inflammatory disorders. Pharmaceutical compositions comprising the compounds of the invention and methods of preparing the compounds of the invention are also disclosed.

US Patent:

20150080382, Mar 19, 2015

Filed:

Jun 24, 2014

Appl. No.:

14/313672

Inventors:

- Atlanta GA, US
Greg Brown - Oakland CA, US
Emmanuel Claret - Besancon, FR
Arwed Cleve - Berlin, DE
David Davey - Landing NJ, US
William Guilford - Belmont CA, US
Seock-Kyu Khim - Orinda CA, US
Thomas Kirkland - Atascadero CA, US
Monica J. Kochanny - Benicia CA, US
Amy Liang - Vallejo CA, US
David Light - San Mateo CA, US
John Parkinson - Martinez CA, US
Guo Ping Wei - San Ramon CA, US
Bin Ye - Moraga CA, US

International Classification:

C07D 487/08
C07D 243/08
C07C 229/08
C07D 409/12
C07D 401/12
C07D 263/14
C07D 405/12

US Classification:

514218, 544137, 5142368, 548453, 514412, 540575, 562451, 514564

Abstract:

This invention is directed to compounds of formula (I):where r, q, R, R, R, R, R, R, R, R, R, R, R, R, and Rare described herein, as single stereoisomers or as mixtures of stereoisomers, or pharmaceutically acceptable salts, solvates, clathrates, polymorphs, ammonium ions, N-oxides or prodrugs thereof; which are leukotriene Ahydrolase inhibitors and therefore useful in treating inflammatory disorders. Pharmaceutical compositions comprising the compounds of the invention and methods of preparing the compounds of the invention are also disclosed.